The Choice of Proton Pump Inhibitor: Does it matter?

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Abstract:

Proton pump inhibitors are used at different dosages for the treatment of acid-related gastrointestinal disorders, such as gastro-oesophageal reflux and peptic ulcer disease. Comparisons of four different proton pump inhibitors: lansoprazole, omeprazole, pantoprazole, and rabeprazole show that they all have similar potency and efficacy. Rabeprazole, however, displays a slightly more rapid onset of acid inhibition than the others; the clinical advantage of this seems limited. The S-isomer of omeprazole, esomeprazole, exhibits a somewhat higher potency than the other proton pump inhibitors. Reports supporting a clinical advantage of this property are not convincing. To conclude, all inhibitors seem comparable as regards inhibition of gastric acid secretion.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1742-7843.2004.pto940302.x

Affiliations: Clinical Pharmacology, Department of Medicine, Karolinska Hospital, Stockholm, Sweden

Publication date: March 1, 2004

More about this publication?
  • Formerly Pharmacology & Toxicology
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more